Jury Finds Pfizer's Protonix Patent Valid
A federal jury has upheld the validity of Pfizer Inc.'s patent covering heartburn treatment Protonix, in a setback for Teva Pharmaceutical Industries Ltd. and other generic-drug makers that had challenged the...To view the full article, register now.
Already a subscriber? Click here to view full article